"Die Klinik für Innere Medizin und Kardiologie versorgt als Klinik der Maximalversorgung erwachsene Patienten mit Herz-Kreislauferkrankungen und allen Schweregraden von Erkrankungen der herznahen Gefäße. Das Leistungsspektrum umfasst alle modernen Methoden der Diagnostik und Therapie, alle Formen der Notfall- und Intensivbehandlung, die auch auf nationalem und internationalem Niveau weiterentwickelt und auch wissenschaftlich bearbeitet werden."

During the past decade, Herzzentrum Dresden conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 9 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 8 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Herzzentrum Dresden" #1 sponsor was "Abbott Medical Devices" with 13 trials, followed by "Abiomed Inc." with 2 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored, "Edwards Lifesciences" with 2 trials sponsored and "Medtronic Cardiovascular" with 2 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herzzentrum Dresden" #1 collaborator was "Boston Scientific Corporation" with 2 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 2 trials as a collaborator, "Universitätsklinikum Hamburg-Eppendorf" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "B. Braun Melsungen AG" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Herzzentrum Dresden" are "Aortic Valve Stenosis" (5 trials), "Atrial Fibrillation" (5 trials), "Coronary Artery Disease" (5 trials), "Stroke" (4 trials) and "Aortic Stenosis" (3 trials). Many other conditions were trialed in "Herzzentrum Dresden" in a lesser frequency.

Most popular intervention types in "Herzzentrum Dresden" are "Device" (38 trials), "Drug" (8 trials), "Procedure" (4 trials), "Combination Product" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AF ablation" (1 trials), "Advisor HD Grid Mapping Catheter, Sensor Enabled" (1 trials), "Angio" (1 trials) and "Ascyrus Medical Dissection Stent (AMDS)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Herzzentrum Dresden" are 52 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Herzzentrum Dresden". undefined are not yet recruiting, 17 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 25 completed trials in Herzzentrum Dresden, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Herzzentrum Dresden, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 21 trials that are defined as “Not Applicable".